XBiotech, Inc. (XBIT - Free Report) was a big mover last session, as its shares rose almost 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Friday’s rally continues the uptrend for the company since Jun 10, as the stock is now up over 10%.
Over the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
XBiotech has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Another favorably ranked stock in the biomedical space is ANI Pharmaceuticals, Inc. (ANIP - Free Report) , sporting a Zacks Rank #1 (Strong Buy).
Is XBIT going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
XBiotech, Inc. (XBIT - Free Report) was a big mover last session, as its shares rose almost 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Friday’s rally continues the uptrend for the company since Jun 10, as the stock is now up over 10%.
Over the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
XBiotech has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Another favorably ranked stock in the biomedical space is ANI Pharmaceuticals, Inc. (ANIP - Free Report) , sporting a Zacks Rank #1 (Strong Buy).
Is XBIT going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on ANIP - FREE
Get the latest research report on XBIT - FREE